ArticleInternational journal of oral science2026
TLR9-engineered photoresponsive biomimetic nanodecoys for targeted NETs clearance to mitigate periodontitis-associated bone resorption.
Article in International journal of oral science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Periodontitis is a widespread and multifactorial inflammatory disease, that leads to the progressive destruction of periodontal tissues and resorption of alveolar bone. The treatment of periodontitis is complicated by complex interactions between the host and oral microbiota, as well as difficulties in obtaining satisfactory treatment effects. Although neutrophil extracellular traps (NETs) participate in the process of disease development induced by periodontitis, their persistent accumulation aggravates inflammatory injury and prevents regenerative processes. Therefore, on the basis of the identification of Toll-like receptor 9 (TLR9) as an important receptor for NETs recognition, a biomimetic and photoresponsive nanodecoy system was designed for the enhanced targeting and efficient degradation of NETs. Taking advantage of the inherent DNA-binding property of TLR9 and incorporating DNase I, this nanodecoy system was designed to drive effective NETs clearance. Under near-infrared radiation, the nanodecoys demonstrate photothermal properties to enhance the clearance of NETs and create an environment conducive to bone regeneration. Moreover, this design inhibits osteoclast overactivation and promotes osteoblast-mediated mineralization to modulate the bone remodeling process. These results demonstrate a promising targeted treatment strategy for periodontitis, which includes the targeting and clearance of NETs and inducing bone regeneration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.